Interferon status and interferon production activity in patients with prolonged community-acquired pneumonia (CAP) - Amsterdam 2025

Community-acquired pneumonia: predicting outcomes and personalising treatment

Chair(s): Markus Fally, Thomas Wilkinson

Session type: Oral presentation

Interferon status and interferon production activity in patients with prolonged community-acquired pneumonia (CAP)

Roman Razumnyi

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Insights into Trimodulins Protective Role in Severe Pneumonia: Evidence from Preclinical Models

Geraldine Nouailles

Replay

Poster

Abstract

Slides

The Long-term Pneumonia Mortality Index. An international multicentre derivation and validation study

Raúl Méndez Ocaña

Replay

Poster

Abstract

Slides

Impact of antimicrobial stewardship on antibiotic prescribing for community acquired pneumonia in the immediate and long-term settings

Athiththa Satchithanandha

Replay

Poster

Abstract

Slides

Interferon status and interferon production activity in patients with prolonged community-acquired pneumonia (CAP)

Roman Razumnyi

Poster

Abstract

Slides

Predicting drug-resistant bacteria causing community-acquired pneumonia; is PES score reliable?

Jatu Aphridasari

Replay

Poster

Abstract

Slides

Activity of immunocompetent cells in patients with acute community-acquired pneumonia

Tamar Saralidze

Poster

Abstract

Slides

Features of severe community-acquired pneumonia (CAP) in Ukraine against the backdrop of russian full-scale military aggression

Anna V Demchuk

Replay

Poster

Abstract

Slides

Streptococcus pneumoniae capsule contributes to lymphocyte immune response failure in bacteremic community-acquired pneumonia.

Francisco Sanz Herrero

Replay

Poster

Abstract

Slides

Evaluation of PSI, CURB-65, and CRB-65 as Prognostic Tools in Hospitalized Immunocompetent Patients with Pneumonia: Real-World Outcomes from Internal Medicine Wards

Liran Levy

Replay

Poster

Abstract

Slides

Azithromycin vs. Doxycycline in Community-Acquired Pneumonia; An Analysis of Clinical Outcomes from the MIMIC IV Database

Wigdan Farah

Replay

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}